ArticleViruses2025

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge.

Gerald K Chege et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.